NEW YORK, March 28 – Genometrix of The Woodlands, Texas, said Wednesday it had reached an agreement to provide SNP-discovery services for Agouron Pharmaceuticals, a subsidiary of Pfizer.

Genometrix did not disclose the terms of the deal, which resulted following a SNP-discovery pilot project.

Spokespeople for Genometrix and Agouron were not immediately available for comment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.